Trending Now
Gryphon Digital Mining (NASDAQ: GRYP) Surges Amidst Bitcoin Frenzy
In today’s rapidly evolving cryptocurrency landscape, Gryphon Digital Mining (GRYP) emerges as a beacon of potential, capitalizing on the resurgent interest in...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Actinium Pharmaceuticals (ATNM) Gains Momentum: Strategic KOL Call Scheduled Amid Radiopharma...
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM), a pioneer in the development of Antibody Radiation Conjugates (ARCs) and targeted radiotherapies, is set to...
MAKE IT MODERN
LATEST REVIEWS
SPY calls could boost today’s session
There is quite a bit of green in both European and domestic markets right now. What I'd be on the lookout for...
MAKE IT MODERN
PERFORMANCE TRAINING
Why Allied Energy (OTCMKTS:AGYP) Occupies a Potent Position in the Energy Patch
Allied Energy (OTCMKTS:AGYP) is a small-cap player in the energy space, but the company has an interesting angle on the production model...
MacroGenics Inc. (NASDAQ: MGNX) Announces Phase 2/3 MAHOGANY and MGC018 Clinical Study Data
MacroGenics Inc. (NASDAQ: MGNX) has announced results from its Cohort A first part of the Phase 2/3 MAHOGANY margetuximab clinical study.
Margetuximab being developed for...
US FDA Grants Approval For Xywav Oral Solution Of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) To...
The US FDA granted approval for Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)’s Xywav oral solution to treat excessive sleep during daytime or narcolepsy.
Jazz received the FDA...
Adial Pharmaceuticals Inc. (NASDAQ:ADIL) Receives Approval For ONWARD Study, To Use COVID-19 Rapid Result...
Adial Pharmaceuticals Inc. (NASDAQ:ADIL) has announced that its breakthrough ONWARD pivotal third phase clinical study in Poland has received approval for the evaluation of...
Markets continue their upward march unabated
Markers continue their upward march unabated. Despite rising death tolls from the coronavirus, equity markets feel obliged to push to new highs....
MAKE IT MODERN
